Nanomaterial-Enabled Electrochemical Biosensing Platforms for Circulating Tumor Cell Analysis.
Circulating tumor cells (CTCs) are valuable liquid biopsy markers for assessing tumor heterogeneity, monitoring minimal residual disease (MRD), and guiding personalized therapy. However, their rarity in blood and phenotypic changes during epithelial-mesenchymal transition (EMT) limit reliable detection. Electrochemical...